Robert J. Alpern

CIK: 0001448074

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)16 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ABT

ABBOTT LABORATORIES

Director

ABBV

AbbVie Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (16 total)

ABT
ABBOTT LABORATORIES
Mar 31, 2026
Award(A)
Stock Equivalent Units
Direct
76 shares at avg. $102.67-
ABBV
AbbVie Inc.
Mar 31, 2026
Award(A)
Stock Equivalent Units
Direct
35 shares at avg. $217.49-
ABT
ABBOTT LABORATORIES
Dec 31, 2025
Award(A)
Stock Equivalent Units
Direct
62 shares at avg. $125.29-
ABBV
AbbVie Inc.
Dec 31, 2025
Award(A)
Stock Equivalent Units
Direct
34 shares at avg. $228.49-
ABBV
AbbVie Inc.
Sep 30, 2025
Award(A)
Stock Equivalent Units
Direct
33 shares at avg. $231.54-
ABT
ABBOTT LABORATORIES
Sep 30, 2025
Award(A)
Stock Equivalent Units
Direct
58 shares at avg. $133.94-
ABBV
AbbVie Inc.
Jun 30, 2025
Award(A)
Stock Equivalent Units
Direct
40 shares at avg. $185.62-
ABT
ABBOTT LABORATORIES
Jun 30, 2025
Award(A)
Stock Equivalent Units
Direct
57 shares at avg. $136.01-
ABBV
AbbVie Inc.
May 9, 2025
Award(A)
Direct
1.2K shares-
ABT
ABBOTT LABORATORIES
Apr 25, 2025
Award(A)
Direct
1.6K shares-
ABT
ABBOTT LABORATORIES
Mar 31, 2025
Award(A)
Stock Equivalent Units
Direct
59 shares at avg. $132.65-
ABBV
AbbVie Inc.
Mar 31, 2025
Award(A)
Stock Equivalent Units
Direct
35 shares at avg. $209.52-
ABT
ABBOTT LABORATORIES
Dec 31, 2024
Award(A)
Stock Equivalent Units
Direct
69 shares at avg. $113.11-
ABBV
AbbVie Inc.
Dec 31, 2024
Award(A)
Stock Equivalent Units
Direct
42 shares at avg. $177.70-
ABBV
AbbVie Inc.
Sep 30, 2024
Award(A)
Stock Equivalent Units
Direct
37 shares at avg. $197.48-
ABT
ABBOTT LABORATORIES
Sep 30, 2024
Award(A)
Stock Equivalent Units
Direct
69 shares at avg. $114.01-

		Type	Shares	Price		Ownership
Mar 31, 2026	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	76	$102.67	-	Direct
Mar 31, 2026	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	35	$217.49	-	Direct
Dec 31, 2025	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	62	$125.29	-	Direct
Dec 31, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	34	$228.49	-	Direct
Sep 30, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	33	$231.54	-	Direct
Sep 30, 2025	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	58	$133.94	-	Direct
Jun 30, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	40	$185.62	-	Direct
Jun 30, 2025	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	57	$136.01	-	Direct
May 9, 2025	ABBV AbbVie Inc.	Award(A)	1,203	-	-	Direct
Apr 25, 2025	ABT ABBOTT LABORATORIES	Award(A)	1,635	-	-	Direct
Mar 31, 2025	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	59	$132.65	-	Direct
Mar 31, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	35	$209.52	-	Direct
Dec 31, 2024	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	69	$113.11	-	Direct
Dec 31, 2024	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	42	$177.70	-	Direct
Sep 30, 2024	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	37	$197.48	-	Direct
Sep 30, 2024	ABT ABBOTT LABORATORIES	Award(A) Stock Equivalent Units	69	$114.01	-	Direct

1-16 of 16 transactions

About Alpern Robert J

Alpern Robert J (SEC CIK 0001448074) files insider reports with the SEC as Director of ABBOTT LABORATORIES (ABT) and Director of AbbVie Inc. (ABBV).

Signal8 holds 16 ownership filings by Alpern Robert J, all Form 4s, filed between Oct 1, 2024 and Apr 2, 2026. Those filings report 16 transactions, from Sep 30, 2024 to Mar 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Alpern Robert J's filings is in NORTH CHICAGO, IL.

Recent filings by Alpern Robert J

Mar 31, 2026: Grant or award of ABT derivative securities (Form 4, code A).
Mar 31, 2026: Grant or award of ABBV derivative securities (Form 4, code A).
Dec 31, 2025: Grant or award of ABT derivative securities (Form 4, code A).
Dec 31, 2025: Grant or award of ABBV derivative securities (Form 4, code A).
Sep 30, 2025: Grant or award of ABBV derivative securities (Form 4, code A).

Other insiders filing for ABBOTT LABORATORIES (ABT)

Stratton John G, Director
Gonzalez Patricia Paola, Director
Conroy Kevin T, Director
Ahuja Nita, Director
Roman Michael F, Director
MCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER

How to read Form 4 transaction codes